Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes
- PMID: 27754946
- DOI: 10.1161/CIRCULATIONAHA.115.020252
Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes
Abstract
Background: The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is a prospective, outcomes-oriented registry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any duration in patients with pacemakers and implantable cardioverter defibrillators (ICDs) and evaluate associations between rigorously adjudicated AT/AF and predefined clinical events, including stroke. The appropriate clinical response to brief episodes of AT/AF remains unclear.
Methods: Rigorously adjudicated electrogram (EGM) data were correlated with adjudicated clinical events with logistic regression and Cox models. Long episodes of AT/AF were defined as episodes in which the onset and/or offset of AT/AF was not present within a single EGM recording. Short episodes of AT/AF were defined as episodes in which both the onset and offset of AT/AF were present within a single EGM recording.
Results: We enrolled 5379 patients with pacemakers (N=3141) or ICDs (N=2238) at 225 US sites (median follow-up 22.9 months). There were 359 deaths. There were 478 hospitalizations among 342 patients for clinical events. We adjudicated 37 531 EGMs; 50% of patients had at least one episode of AT/AF. Patients with clinical events were more likely than those without to have long AT/AF (31.9% vs. 22.1% for pacemaker patients and 28.7% vs. 20.2% for ICD patients; P<0.05 for both groups). Only short episodes of AT/AF were documented in 9% of pacemaker patients and 16% of ICD patients. Patients with clinical events were no more likely than those without to have short AT/AF (5.1% vs. 7.9% for pacemaker patients and 11.5% vs. 10.4% for ICD patients; P=0.21 and 0.66, respectively).
Conclusions: In the RATE Registry, rigorously adjudicated short episodes of AT/AF, as defined, were not associated with increased risk of clinical events compared with patients without documented AT/AF.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00837798.
Keywords: anti-coagulation; atrial fibrillation; defibrillators; pacemakers; stroke; trials.
© 2016 American Heart Association, Inc.
Similar articles
-
Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording.Europace. 2006 Nov;8(11):950-61. doi: 10.1093/europace/eul112. Europace. 2006. PMID: 17043069 Clinical Trial.
-
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6. Heart Rhythm. 2018. PMID: 29981863 Clinical Trial.
-
Is competitive atrial pacing a possible trigger for atrial fibrillation? Observations from the RATE registry.Heart Rhythm. 2021 Jan;18(1):3-9. doi: 10.1016/j.hrthm.2020.07.028. Epub 2020 Jul 30. Heart Rhythm. 2021. PMID: 32738404
-
Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.Europace. 2015 Oct;17 Suppl 2:ii40-6. doi: 10.1093/europace/euv235. Europace. 2015. PMID: 26842114 Review.
-
Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.Card Electrophysiol Rev. 2003 Dec;7(4):341-4. doi: 10.1023/B:CEPR.0000023134.41562.79. Card Electrophysiol Rev. 2003. PMID: 15071249 Review.
Cited by
-
Using Atrial Fibrillation Burden Trends and Machine Learning to Predict Near-Term Risk of Cardiovascular Hospitalization.Circ Arrhythm Electrophysiol. 2024 Nov;17(11):e012991. doi: 10.1161/CIRCEP.124.012991. Epub 2024 Oct 24. Circ Arrhythm Electrophysiol. 2024. PMID: 39445440 Free PMC article.
-
Challenging anticoagulation decisions in atrial fibrillation: a narrative review.Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241290429. doi: 10.1177/17539447241290429. Ther Adv Cardiovasc Dis. 2024. PMID: 39413210 Free PMC article. Review.
-
Atrial Fibrillation in Hypertrophic Cardiomyopathy.JACC Adv. 2024 Aug 20;3(9):101210. doi: 10.1016/j.jacadv.2024.101210. eCollection 2024 Sep. JACC Adv. 2024. PMID: 39247675 Free PMC article. Review.
-
Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions.Rev Cardiovasc Med. 2024 Aug 22;25(8):305. doi: 10.31083/j.rcm2508305. eCollection 2024 Aug. Rev Cardiovasc Med. 2024. PMID: 39228483 Free PMC article. Review.
-
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2024 Jan 2;83(1):109-279. doi: 10.1016/j.jacc.2023.08.017. Epub 2023 Nov 30. J Am Coll Cardiol. 2024. PMID: 38043043 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
